Skip to main content

Advertisement

SpringerLink
Log in

D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Hemangioblastomas (HB) are characterized by the presence of vacuolated tumor cells resembling the tumor cells seen in clear cell renal cell carcinomas (CRCC). The distinction between HB and metastatic CRCC in the brain is critical as they have different therapeutic and prognostic ramifications. The issue is further complicated by the possibility of both HB and metastatic CRCC in brains of patients with Von Hippel Lindau (VHL) disease. We studied the expression of a novel monoclonal antibody D2-40, which recognizes an oncofetal antigen (M2A) in HB and CRCC, by immunohistochemistry. The vacuolated tumor cells in all HB were stained positively with D2-40. Nineteen of 23 (83%) HB showed strong, membranous staining in the vacuolated tumor cells, and 4 of 23 (17%) showed weaker staining. No expression was seen in CRCC, either primary in the kidney (0/20), or metastatic CRCC in the brain (0/8). Three of the patients with HB also had VHL disease, and no difference was seen in D2-40 staining of HB in patients with or without VHL disease. Two of these three VHL disease patients had both primary CRCC and HB resected at our institution. In these two patients, strong D2-40 expression was seen in the HB, but no expression was seen in the CRCC, underlying the utility of this marker in distinguishing HB from CRCC in patients with VHL disease in addition to sporadic cases. In summary, the monoclonal antibody D2-40 is a useful marker to distinguish HB from CRCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Andrew SM, Gradwell E (1986) Immunoperoxidase labeled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas. J Clin Pathol 39:917–919

    Google Scholar 

  2. Bailey D, Baumal R, Law J, Sheldon K, Kannampuzha P, Stratis M, Kahn H, Marks A (1986) Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA 83:5291–5295

    Google Scholar 

  3. Bailey D, Marks A, Stratis M, Baumal R (1991) Immunohistochemical staining of germ cell tumours and intratubular malignant germ cells of the testis using antibody to placental alkaline phosphate and a monoclonal anti-seminoma antibody. Mod Pathol 4:167–171

    Google Scholar 

  4. Bleistein M, Geiger K, Franz K, Stoldt P, Schlote W (2000) Transthyretin and transferrin in hemangioblastoma stromal cells. Pathol Res Pract 196:675–681

    Google Scholar 

  5. Bret P, Streichenberger N, Guyotat J (1999) Metastasis of renal carcinoma to a cerebellar hemangioblastoma in a patient with von Hippel Lindau disease: a case report. Br J Neurosurg 13:413–416

    Google Scholar 

  6. Brown DF, Dababo MA, Hladik CL, Eagan KP, White CL 3rd, Rushing EJ (1998) Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas. Mod Pathol 11:55–59

    Google Scholar 

  7. Burger PC, Scheithauer BW, Vogel FS (1991) Surgical pathology of the nervous system and its coverings, 3rd edn. Churchill Livingstone, New York, pp 373–386

  8. Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN (2004) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 17:1–10

    Google Scholar 

  9. Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D (2001) Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48:55–63

    Google Scholar 

  10. Feldenzer JA, McKeever PE (1987) Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas. Acta Neuropathol (Berl) 72:281–285

    Google Scholar 

  11. Frank TS, Trojanowski JQ, Roberts SA, Brooks JJ (1989) A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor. Mod Pathol 2:638–651

    Google Scholar 

  12. Gouldesbrough DR, Bell JE, Gordon A (1988) Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal cell carcinoma. J Clin Pathol 41:861–865

    Google Scholar 

  13. Hoang MP, Amirkhan RH (2003) Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol 27:1152–1156

    Google Scholar 

  14. Ismail SM, Jasani B, Cole G (1985) Histogenesis of hemangioblastomas: an immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome. J Clin Pathol 38:417–421

    Google Scholar 

  15. Jung SM, Kuo TT (2003) Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol Dec 2004 (Advanced online publication)

  16. Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255–1257

    Google Scholar 

  17. Kahn HJ, Bailey D, Marks A (2002) Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol 15:434–440

    Google Scholar 

  18. Lach B, Gregor A, Rippstein P, Omulecka A (1999) Angiogenic histogenesis of stromal cells in hemangioblastomas: ultrastructural and immunohistochemical study. Ultrastruct Pathol 23:299–310

    Google Scholar 

  19. Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R (1999) Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 80:569–578

    Google Scholar 

  20. Miller CR, Perry A (2004) Immunohistochemical differentiation of hemangioblastoma from metastatic clear cell renal carcinoma: an update. Adv Anat Pathol 11:325–326

    Google Scholar 

  21. Murakata LA, Ishak KG, Nzeako UC (2000) Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol 13:874–881

    Google Scholar 

  22. Omulecka A, Lach B, Alwasiak J, Gregor A (1995) Immunohistochemical and ultrastructural studies of stromal cells in hemangioblastomas. Folia Neuropathol 33:41–50

    Google Scholar 

  23. Scavelli C, Weber E, Agliano M, Cirulli T, Nico B, Vacca A, Ribatti D (2004) Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J Anat 204:433–449

    Google Scholar 

  24. Sim SJ, Ro JY, Ordonez NG, Park YW, Kee KH, Ayala AG (1999) Metastatic CRCC to the bladder: a clinicopathologic and immunohistochemical study. Mod Pathol 12:351–355

    Google Scholar 

  25. Zakharov A, Papaiconomou C, Djenic J, Midha R, Johnston M (2003) Lymphatic cerebrospinal fluid absorption pathways in neonatal sheep revealed by subarachnoid injection of Microfil. Neuropathol Appl Neurobiol 29:563–573

    Google Scholar 

Download references

Acknowledgements

The authors are grateful to John C. Oberholtzer for many helpful discussions. We thank Ms. Theresa L. Pasha for her excellent technical expertise in performing the immunohistochemical stains.

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 3400 Spruce Street, 6 Founders, Philadelphia, PA, 19104, USA

    Subhojit Roy, Albert Chu, John Q. Trojanowski & Paul J. Zhang

Authors
  1. Subhojit Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Q. Trojanowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul J. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul J. Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roy, S., Chu, A., Trojanowski, J.Q. et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol 109, 497–502 (2005). https://doi.org/10.1007/s00401-005-0999-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-005-0999-3

Keywords

Search

Navigation